3 TSX Growth Companies With Up To 22% Insider Ownership
In This Article:
Over the last 7 days, the Canadian market has dropped 2.3%, driven by losses of 4.8% and 6.4%. However, in the past year, the market is up 12%, with earnings forecast to grow by 15% annually. In this context, identifying growth companies with significant insider ownership can be a strategic move for investors looking for stability and potential upside in a fluctuating market environment.
Top 10 Growth Companies With High Insider Ownership In Canada
| Name | Insider Ownership | Earnings Growth |
| Vox Royalty (TSX:VOXR) | 12.5% | 70.7% |
| Allied Gold (TSX:AAUC) | 22.5% | 73.5% |
| Almonty Industries (TSX:AII) | 17.7% | 117.6% |
| goeasy (TSX:GSY) | 21.2% | 17.1% |
| Alvopetro Energy (TSXV:ALV) | 19.4% | 72.4% |
| Propel Holdings (TSX:PRL) | 40% | 37.2% |
| VersaBank (TSX:VBNK) | 13.3% | 28.2% |
| Medicenna Therapeutics (TSX:MDNA) | 15.4% | 57.2% |
| Alpha Cognition (CNSX:ACOG) | 17.9% | 69.5% |
| ROK Resources (TSXV:ROK) | 16.6% | 161.8% |
Let's dive into some prime choices out of the screener.
Knight Therapeutics
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Knight Therapeutics Inc. develops, manufactures, acquires, licenses, markets, and distributes pharmaceutical and consumer health products as well as medical devices worldwide with a market cap of CA$570.85 million.
Operations: Revenue from pharmaceuticals amounted to CA$337.87 million.
Insider Ownership: 22.3%
Knight Therapeutics has substantial insider ownership, indicating strong internal confidence. Despite a recent net loss of CAD 1.94 million for Q2 2024, the company raised its annual revenue guidance to between CAD 355 million and CAD 365 million. The stock trades significantly below its estimated fair value, suggesting potential upside. Knight is also actively repurchasing shares, having bought back over 6 million shares recently, which may positively impact shareholder value in the long term.
Savaria
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Savaria Corporation offers accessibility solutions for the elderly and physically challenged individuals across Canada, the United States, Europe, and internationally, with a market cap of CA$1.43 billion.
Operations: The company's revenue segments include Patient Care at CA$183.98 million and Segment Adjustment at CA$673.74 million.
Insider Ownership: 19.6%
Savaria Corporation exhibits high insider ownership, aligning with its robust growth profile. The company reported a significant earnings increase, with Q2 2024 net income rising to CAD 10.96 million from CAD 8.79 million year-over-year. Revenue is forecast to grow at 7.4% annually, outpacing the Canadian market average of 6.7%. Despite recent shareholder dilution, analysts project a stock price rise by 21.2%, and insiders have shown confidence through recent share purchases, albeit in modest volumes.